Skip to content

Interventions to curb hepatitis C reinfections among men who have sex with men.

Interventions to curb hepatitis C reinfections among men who have sex with men. - ICECREAM study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON54537
Enrollment
246
Registered
2019-07-31
Start date
2019-11-18
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HCV infection Hepatitis C virus infection

Interventions

Intervention I is a targeted, online behavioural intervention developed as part of the project. Intervention II consists of an additional patient-initiated, home-based HCV RNA testing service with t

Sponsors

GGD Amsterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Men who have sex with men >= 18 years - History of a prior HCV infection (succesfully treated or spontaneously cleared)

Exclusion criteria

Exclusion criteria: - Acute or chronic HCV infection at time of enrolment (positive HCV RNA). - Under HCV treatment at time of enrolment. - Unlikely, in the opinion of the clinician, to comply with the study procedures. - Currently participating in an intervention study that offers extra HCV testing and/or a behavioural intervention. - Investigators and other dependent persons.

Design outcomes

Primary

MeasureTime frame
The primary outcome is the proportion at risk of HCV reinfection (as determined by a HCV-MOSAIC risk score >= 2) during the run-in versus intervention periods. This risk score consists of 6 items related to the risk of HCV and is calculated by summing up the bèta's of the items when present in the past 6 months: 1. Receptive condomless anal sex (beta 1.1) 2. Sharing of sex toys (beta 1.2) 3. Unprotected fisting (beta 0.9) 4. Injecting drug use (beta 1.4) 5. Sharing of straws during nasally-administered drug use (beta 1.0) 6. Ulcerative sexually transmitted infection (beta 1.4)

Secondary

MeasureTime frame
Secondary outcomes include HCV reinfection incidence, changes in individual risk behaviour items of the HCV-MOSAIC risk score and changes in sexual wellbeing.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)